CYTOKINETICS INC — Director's Dealing 2025

Apr 21, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-04-21

Reporting Person: WIERENGA WENDALL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-04-21	Common Stock	M	20000	$6.21	Acquired	44848	Direct
2025-04-21	Common Stock	S	20000	$38.46	Disposed	24848	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-21	Stock Option (Right to Buy)	$6.21	M	20000	Disposed	2025-05-20	Common Stock (20000)	Direct

Footnotes

F1: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 20, 2016.